Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK – 18 ...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of Oxford Biomedica plc ( LON:OXB ), it sends a favourable ...

Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today Oxford, UK – 2 September 2024: Oxford Biomedica plc ...

The United Kingdom's FTSE 100 index recently experienced a downturn, closing 0.4% lower at 7,527.42 due to weak trade data from China, highlighting the ongoing struggles of the global economy ...

Oxford, UK – 2 September 2024: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica”, "OXB" or “the Company”), a quality and innovation-led cell and gene therapy CDMO, announces that ...

Researchers have found evidence that low oxygen levels in tumors could actually enhance some of the body's immune responses against cancer, in contrast with the general paradigm that hypoxia ...

According to the Office for National Statistics on Friday, UK retail sales volumes rose 1.0% in August from July, beating FXStreet-cited consensus of 0.4%. They had risen 0.7% in July from June. That ...

In the complex landscape of cancer, tumors create their own microenvironment, often marked by low oxygen levels, a condition known as hypoxia.

The RESILIENCE clinical trial has been designed to explore the effectiveness and safety of remote ischemic conditioning (RIC) ...

Researchers have identified five independent factors that predict cancer patients' response to checkpoint inhibitors (CPIs). The study validates these factors in more than 1,400 patients and diverse ...